List view / Grid view
11 July 2016 | By Victoria White, Digital Content Producer
The SMC has accepted five new medicines for routine use in NHS Scotland including lung cancer treatments nivolumab and crizotinib...
6 July 2016 | By Victoria White, Digital Content Producer
The EC has extended the current conditional marketing authorisation of Adcetris as consodlidation treatment in post-transplant Hodgkin lymphoma...
5 July 2016 | By Victoria White, Digital Content Producer
Cx601 is a suspension of allogeneic adipose-derived stem cells injected intra-lesionally for the treatment of complex perianal fistulas in Crohn’s disease...
4 July 2016 | By Victoria White, Digital Content Producer
Takeda and Altos have entered into an agreement to further the develop Altos’s proprietary compound ATC-1906 for the treatment of gastroparesis...
21 June 2016 | By Victoria White, Digital Content Producer
Takeda has dosed the first subject in a Phase IIb field efficacy trial of its norovirus vaccine candidate, TAK-214...
17 June 2016 | By Victoria White, Digital Content Producer
Takeda and M2Gen are to collaborate with ORIEN to speed the development of cancer therapeutics through health informatics...
7 June 2016 | By Victoria White, Digital Content Producer
Myovant Sciences is a biopharmaceutical company focused on delivering innovative women’s health and prostate cancer therapeutics...
27 May 2016 | By Victoria White, Digital Content Producer
The opinion is for Adcetris for the treatment of adult patients with CD30+ Hodgkin lymphoma at increased risk of relapse or progression following ASCT...
24 May 2016 | By Victoria White, Digital Content Producer
Vedolizumab is the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active UC...
10 May 2016 | By Victoria White, Digital Content Producer
Takeda has received $38 million grant from the Bill & Melinda Gates Foundation to support global polio eradication in developing countries...
In this Single Use In-Depth Focus: Disposables for continuous viral clearance for the production of monoclonal antibodies; Managing the quality of biologics manufactured by single use systems: A Japanese perspective; Single Use Q&A...
29 March 2016 | By Victoria White
The FDA have issued a CRL to include new data in the clinical trials section of the US label of Brintellix for treating aspects of cognitive dysfunction in MDD...
4 February 2016 | By Victoria White
The FDA Advisory Committee reviewed data from studies designed to assess the effect of Brintellix on cognitive dysfunction in adult patients with MDD...
25 January 2016 | By Victoria White
Ninlaro (ixazomib) was recently approved by the FDA, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma...
22 January 2016 | By Victoria White
The EC has approved the Type II variation for Adcetris to include data on the retreatment of adult patients with R/R Hodgkin lymphoma or R/R sALCL who previously responded to Adcetris and who later relapse....
